Teligent Inc
TLGT
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $94.92 Million |
| Dividend Yield | $47.50 (-) |
| Earnings per Share | $0 |
| Beta | 1.62 |
| Outstanding Shares | 93,410,017 |
Return
| Return on Equity | 18.99% |
|---|---|
| Return on Assets | -12.37% |
| Return on Invested Capital | -4.00% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.17 |
| Enterprise Value to Revenue | 2.05 |
| Enterprise Value to EBIT | -30.5 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 1.24 |
| Debt to Equity | -2 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Teligent Inc
CEO: Timothy Sawyer Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market.